Human neutrophil peptides 1, 2 and 3 (HNP 1-3): Elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis

Human and Experimental Toxicology

Volumn 32, Issue 2, 2013, Pages 167-171

  Kemik, O ^a   Kemik, A S ^b   Sumer, A ^a   Begenik, H ^a   Purisa, S ^c   Tuzun, S ^d  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Haseki Training Hospital   (Turkey)

Author keywords

colorectal cancer; hepatic metastasis; human neutrophil peptides; lymph node metastasis

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 1; ALPHA DEFENSIN 2; ALPHA DEFENSIN 3; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ALPHA-DEFENSINS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84872282919     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111412802     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2007 ; 57: 43-66
2. Bond JH. Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis. 2000 ; 11: 176-184
3. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002 ; 89: 845-860
4. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992 ; 326: 658-662
5. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999 ; 91: 434-437
6. Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol. 2005 ; 23: 378-391
7. Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2002 ; 52: 8-22
8. Ihi T, Nakazato M, Mukae H, matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997 ; 25: 1134-1140
9. Panyutich AV, Panyutich EA, Krapivin VA, Baturevich EA, Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993 ; 2: 202-207
10. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol. 2001 ; 4: 1491-1502
11. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S, et al. Defensin-1, a peptide detected in the saliva of oral squampus cell carcinoma patients. Anticancer Res. 1998 ; 6B: 4645-4649
12. Zhou L, Huang LQ, Beuerman RW, Grigg ME, Li SF, Chew FT, et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res. 2004 ; 3: 410-416
13. Bateman A, Singh A, Jothy S, Fraser R, Esch F, Soloman S. The levels and biologic action of the human neutrophil granule peptide HP-1 in lung tumors. Peptides. 1992 ; 1: 133-139
14. Mizukawa N, Sugiyama K, Kamio M, Yamachika E, Ueno T, Fukunaga J, et al. Immunohistochemical staining of human alpha-defensin-1 (HNP-1), in the submandibular glands of patients with oral carcinomas. Anticancer Res. 2000 ; 2B: 1125-1127
15. Lundy FT, Orr DF, Gallagher JR, Maxwell P, Shaw C, Napier SS, et al. Identification and overexpression of human neutrophil alpha-defensin (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue. Oral Oncol. 2004 ; 2: 139-144
16. Cunliffe RN. Alpha-defensins in the gastrointestinal tract. Mol Immunol. 2003 ; 7: 463-467
17. Van Wetering S, Mannesse-Lazeroms SP, Van Sterkenburg MA, Daha MR, Dijkman JH, Hiemstra PS. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol. 1997 ; 272: L888-896
18. Lichtenstein A, Ganz T, Selsted ME, Lehrer RI. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood. 1986 ; 6: 1407-1410
19. Misuno NI, Kolesnikova TS, Lerer RI, Gants T, Voltenok NN. Effects of human defensin HNP-1 on the production of tumor necrosis factor-alpha by human blood monocytes in vitro. Biuli Eksp Biol Med. 1992 ; 5: 524-527
20. Halder TM, Bluggel M, Heinzel S, Pawelec G, Meyer HE, Kalbacher H. Defensins are dominant HLA-DR-associated self-peptides from CD34(-) peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia). Blood. 2000 ; 9: 2890-2896
21. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999 ; 5439: 525-28
22. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity. More than just microbicidal. Trends Immunol. 2002 ; 6: 291-296
23. Welling MM, Hiemstra PS, van den Barselaar MT, Paulusma-Annema A, Nibbering PH, Pauwels EK, et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest. 1998 ; 8: 1583-1590
24. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet. 2001 ; 9255: 539-545
25. van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol. 2003 ; 11: 539-548
26. Van den Broek I, Sparidans RW, Engwegen JY, et al. Evaluation of human neutrophil peptides as serum for colorectal cancer. Cancer Biomark. 2010 ; 7: 109-115